Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nexus Evaluation Primary Trident II UNcemented shEll (NEPTUNE): A Longitudinal Cohort Study of the Hydroxyapatite Coated Trident II Acetabular System in Total Hip Arthroplasty

NCT05366712 is registered in ClinicalTrials.gov with NHS Lothian as lead sponsor.

NCT NCT05366712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nexus Evaluation Primary Trident II UNcemented shEll (NEPTUNE): A Longitudinal Cohort Study of the Hydroxyapatite Coated Trident II Acetabular System in Total Hip Arthroplasty
Lead sponsor
NHS Lothian
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 1, 2022
Completion date
November 25, 2034
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis of hip, hip arthropathy, hip dysplasia, hip osteoarthritis